Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rene Westhovens

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Rheumatology (Oxford, England)|February 27, 2019
Clinical efficacy of new JAK inhibitors under development. Just more of the same?Rene Westhovens
Expert Review of Clinical Immunology|November 29, 2021
CT-P13 SC for the treatment of rheumatoid arthritisRene Westhovens
Expert Review of Clinical Immunology|November 17, 2022
Filgotinib in rheumatoid arthritisRene Westhovens
Rheumatology (Oxford, England)|October 3, 2017
The use of glucocorticoids in early rheumatoid arthritisPatrick Verschueren, Rene Westhovens
RMD Open|September 22, 2016
Costs of drugs for treatment of rheumatic diseasesRene Westhovens, Lieven Annemans
Arthritis Research & Therapy|November 26, 2008
Translating co-stimulation blockade into clinical practiceRene Westhovens, Patrick Verschueren
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
The efficacy and safety of abatacept in rheumatoid arthritisRene Westhovens, Patrick Verschueren
Annals of the Rheumatic Diseases|March 6, 2012
Provisional diagnostic criteria for polymyalgia rheumatica: moving beyond clinical intuition?Robert Spiera, Rene Westhovens
Annals of the Rheumatic Diseases|June 16, 2009
Methotrexate: the gold standard without standardisationJonathan Kay, Rene Westhovens
Nature Reviews. Rheumatology|July 4, 2012
Rheumatoid arthritis: defining remission in patients with RA in clinical practiceRene Westhovens, Patrick Verschueren
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Rheumatology (Oxford, England)|February 27, 2019
Clinical efficacy of new JAK inhibitors under development. Just more of the same?Rene Westhovens
Expert Review of Clinical Immunology|November 29, 2021
CT-P13 SC for the treatment of rheumatoid arthritisRene Westhovens
Expert Review of Clinical Immunology|November 17, 2022
Filgotinib in rheumatoid arthritisRene Westhovens
Rheumatology (Oxford, England)|October 3, 2017
The use of glucocorticoids in early rheumatoid arthritisPatrick Verschueren, Rene Westhovens
RMD Open|September 22, 2016
Costs of drugs for treatment of rheumatic diseasesRene Westhovens, Lieven Annemans
Arthritis Research & Therapy|November 26, 2008
Translating co-stimulation blockade into clinical practiceRene Westhovens, Patrick Verschueren
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
The efficacy and safety of abatacept in rheumatoid arthritisRene Westhovens, Patrick Verschueren
Annals of the Rheumatic Diseases|March 6, 2012
Provisional diagnostic criteria for polymyalgia rheumatica: moving beyond clinical intuition?Robert Spiera, Rene Westhovens
Annals of the Rheumatic Diseases|June 16, 2009
Methotrexate: the gold standard without standardisationJonathan Kay, Rene Westhovens
Nature Reviews. Rheumatology|July 4, 2012
Rheumatoid arthritis: defining remission in patients with RA in clinical practiceRene Westhovens, Patrick Verschueren
Pageof 13